Also TGFβ2 was significantly positively correlated with EMT score and mesenchymal markers (CDH2, VIM and ZEB1), and in STAD, there was no significance in the analysis between TGFβ2 and CDH1. The gene discussed is TGFB2; the disease is gastric adenocarcinoma.